NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/12/2024
Voltar para busca
Dado oficial do USPTO
AAVALABS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
28/12/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
14/01/2021
Data de registro
08/02/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/02/2022
Última transação
08/02/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FI
Examinador
SANTIAGO, ALEXIS
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a rectangle with a straight left, top, and right side with the bottom side forming a silhouette of four mountain peaks. Below is the wording AAVALABS in stylized, block text.
Titulares e representantes
Titulares
Nordic By Nature Oy
Representantes
Geza C. Ziegler Jr. ZIEGLER IP LAW GROUP LLC.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; pharmaceuticalspsychotropics and natural remedy preparations for the treatment of gastro-intestinal conditionshormonal and chemical imbalancessleep disorders; vitamin a preparations; alginate dietary supplements; food supplements consisting of amino acids; food supplementsantioxidants; anti-oxidant food supplements; asthmatic tea; meal replacement powders adapted for medical use; vitamin b preparations; vitamin c preparations; vitamin d preparations; artificial sweeteners adapted for diabetics; dietary and nutritional supplements; dietary supplements consisting of vitamins; nutraceuticals for use as a dietary supplement; dietetic confectionery adapted for medical purposes; dietary supplements for controlling cholesterol; dietetic foods adapted for medical use; dietary supplemental drinks; mineral food supplements; enzyme dietary supplements; glucose for use as an additive to foods for medical purposes; powdered fruit-flavored dietary supplement drink mix; glucose dietary supplements; food supplements consisting of trace elements; cod liver oil; dietetic beverages adapted for medicinal purposes; edible fish oil for medical purposes; casein dietary supplements; mineral nutritional supplements; mineral dietary supplements for humans; mineral food supplements; mineral water salts for medical purposes; dietary fiber to aid digestion; medicinal tea; diet capsules; slimming pills; baby food; nutritional supplements; dietary supplements for humans; lecithin dietary supplements; lipotropic factor preparations; health food supplements for persons with special dietary requirements; lysine preparations; royal jelly dietary supplements; multi-vitamin preparations; multi-vitamin preparations; liquid vitamin supplements; liquid herbal supplements; nutritional supplements consisting primarily of calcium; nutritional supplements consisting primarily of magnesium; nutritional supplements consisting primarily of iron; nutritional supplements consisting primarily of zinc; health food supplements made principally of minerals; health food supplements made principally of vitamins; freeze-dried food adapted for medical purposes; flaxseed dietary supplements; ground flaxseed fiber for use as a dietary supplement; flaxseed oil dietary supplements; probiotic supplements; protein dietary supplements; dietary supplements consisting primarily of iron; dietary supplements consisting primarily of magnesium; dietary supplements consisting primarily of calcium; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; powdered nutritional supplement drink mix; appetite suppressants; appetite stimulant preparations; appetite suppressants; dietary supplements for humans not for medical purposes; nutritional supplements consisting of fungal extracts; bee pollen for use as a dietary food supplement; pollen dietary supplements; zinc supplement lozenges; soy isoflavone dietary supplements; soy protein dietary supplements; starch for pharmaceutical purposes; colostrum supplements; cod-liver oil capsules; cod-liver oil drops; albumin dietary supplements; wheat germ dietary supplements; wheat for use as dietary supplements; by-products of the processing of cereals for dietetic or medical purposes; vitamin and mineral supplements; dietary supplemental drinks in the nature of vitamin and mineral beverages; gummy vitamins; vitamin supplements; vitamin supplements for use in renal dialysis; effervescent vitamin tablets; vitamins and vitamin preparations; vitamin tablets; vitamin drops; vitamin preparations; vitamin preparations in the nature of food supplements; mixed vitamin preparations; herbal dietary supplements for persons with special dietary requirements; herbal dietary supplements for persons with special dietary requirements
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/11/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/12/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/07/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/08/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/07/2022
FIMP
FINAL DISPOSITION PROCESSED
18/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
06/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/11/2021
PUBO
PUBLISHED FOR OPPOSITION
23/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2021
RFNT
REFUSAL PROCESSED BY IB
20/09/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/08/2021
RFRR
REFUSAL PROCESSED BY MPU
26/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/08/2021
CNRT
NON-FINAL ACTION WRITTEN
12/08/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/08/2021
DOCK
ASSIGNED TO EXAMINER
03/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AAVALABS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.